Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JUVIA Zinc-containing Vaginal Gel and Fluconazole for Vulvovaginal Candidiasis
NCT05895162Completed
- Sponsor
- Fempharma
- Start
- Jun 2023
- Primary completion
- Apr 2026
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of JUVIAGEL in vulvovaginal candidiasis (VVC) (2 arms), sponsored by Fempharma. Primary endpoint: Clinical cure at 12 weeks. Started Jun 2023; status: completed.
02
Drugs
JUVIAGEL
03
Conditions
vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on NCT05895162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05895162.